As for female breast cancer, a recent meta-analysis carried out across three large whole-exome sequencing datasets pointed to an association between deleterious protein-truncating or missense variants in CDKN2A and breast cancer at exome-wide significance [20]. This evidence concerns the gene CDKN2A and breast carcinoma.